03-05-2023 : 769 Pharmacists work as Medical Representative, of which 39 work as Senior Medical Representative * 02-06-2020 : 216 non Pharmacists work as Medical Representative, and 54 work as Senior Medical Representative * 05-06-2023 : In Lebanon, 88 generic medicinal products are more expensive than their Originators * 31-12-2019 : A medicinal product refused in Europe is marketed in Lebanon * 05-06-2023 : At least 332 medicinal products are available on the Lebanese market and are not available in the country of origin * 05-06-2023 : The price of the most expensive medicine available in Lebanon is 30434557 LL * 05-06-2023 : At least 1309 medicinal products are more expensive in Lebanon than in the countries of origin * 01-01-2019 : Daktavira, a generic of Daklinza, is registered in Lebanon but has no public price * 31-12-2019 : 352 medicinal products have been declared as non-marketed or withdrawn * 09-11-2021 : 64.72% of lebanese pharmacists are female * 31-12-2019 : 486 medicines were submitted to the Ministry of Health for a marketing authorization, and 514 medicines were registered to date * 15-06-2018 : The Minister of Public Health, has decided to suspend the commercialization of AB Slim (Ab Care Medical Herbs), which contains sibutramine, sildenafil and phenolphthalein * 01-06-2020 : Some Non-Marketed medicines are still imported * 01-06-2020 : Ixempra, a medicinal product withdrawn in Europe is imported to lebanon * 01-06-2020 : A vaccine made in India, removed from WHO list of prequalified vaccines, is submitted for registration in Lebanon * 01-06-2020 : Lebanon has 14 CROs, and is ranked as one of the largest countries in the world in clinical studies. According to the WHO, 817 clinical studies are currently conducted in Lebanon. * 05-01-2021 : * 01-10-2023 : Adakveo is now withdrawn from use in the European Union due to lack of therapeutic efficacy *
Fortum 1g* : | |
Type | Medicine Withdrawn |
Originator | B |
Agent | Abela Freres |
Distributor | Abela Freres |
Laboratory | GSK |
Responsible Party | GlaxoSmithKline Manufacturing SpA |
Origin | Italy |
Manufacturer | GlaxoSmithKline Manufacturing SPA |
Origin | Italy |
ATC | J01DD02 |
Fortum 1g* :
Fortum 1g* :
Fortum 1g* :
Fortum 1g* :
Fortum 1g* :
Hazard Level |
---|
◼ Major |
◼ Moderate |
◼ Minor |
◼ Safe |
Fortum 1g* :
Fortum 1g* :
Frequency | Percentage |
---|---|
Very Common | ≥ 1/10 |
Common | ≥ 1/100 - < 1/10 |
Uncommon | ≥ 1/1,000 - < 1/100 |
Rare | ≥ 1/10,000 - < 1/1,000 |
Very Rare | < 1/10,000 |
Unknown | Cannot be Estimated |
Effect | Frequency |
---|---|
Abdominal pain | Uncommon |
Agranulocytosis | Not known |
Anaphylaxis | Not known |
Angioedema (Angioneurotic oedema) (Quincke oedema) | Not known |
Antibiotic-associated diarrhea | Uncommon |
Blood urea increased | Uncommon |
Blood urea nitrogen (BUN) increased | Uncommon |
Bronchospasm | Not known |
Candidiasis (Candida infection) | Uncommon |
Colitis | Uncommon |
Coombs direct test positive | Common |
Diarrhoea (Diarrhea) | Common |
Dizziness | Uncommon |
DRESS (Drug reaction with eosinophilia and systemic symptoms) | Not known |
Dysguesia (taste perversion) (Taste abnormality) (Taste disturbance) | Not known |
Eosinophilia | Common |
Erythema multiforme | Not known |
Fever | Uncommon |
Haemolytic anemia | Not known |
Headache | Uncommon |
Hepatic enzyme increased | Common |
Hypotension | Not known |
Injection site inflammation | Common |
Injection site pain | Common |
Interstitial nephritis | Very rare |
Jaundice | Not known |
Leucopenia (Leukopenia) | Uncommon |
Lyell Syndrome (Toxic epidermal necrolysis) | Not known |
Lymphocytosis | Not known |
Maculopapular rash | Common |
Nausea | Uncommon |
Neurological symptom | Not known |
Neutropenia | Uncommon |
Oral thrush | Uncommon |
Paraesthesia (paresthesia) | Not known |
Phlebitis | Common |
Pruritus | Uncommon |
Renal failure acute (Acute renal insufficiency) (Kidney failure acute) (Renal insufficiency acute) | Very rare |
Serum creatinine increased | Uncommon |
Stevens-Johnson syndrome | Not known |
Thrombocytopenia (Thrombopenia) | Uncommon |
Thrombocytosis | Common |
Thrombophlebitis | Common |
Urticarial rash (Nettle rash) | Common |
Vaginitis | Uncommon |
Vomiting | Uncommon |
Fortum 1g* :
Fortum 1g* :
NB : Products With Same Indication |
Different Units By MoH Code
Fortum 1g* MoH 595 :
Form | Powder and solvent for solution for injection |
Packaging | Vial (Type III Glass) |
Package Size | 1+1 |
Strength | 1g |
Storage Condition | <25°C protect from light |
NSSF | ✘ |
Quarantine | ✘ |
Reg. Number | 26069 |
Submission date | 01/01/1987 |
Registration Year | 1987 |
Archived Date | 02/07/2020 |
Withdrawn Date | 03/05/2023 |
Price Comparison
● Country: | Switzerland | |
● Package Size: | 1 | |
● Public Price: | 27.35 CHF | ( 2,828,537.00 LBP ) |
● Pack size unit used: | 1 | |
● Cost/Unit: | 27,35 CHF | ( 2,792,340.00 LBP ) |
● Exfactory Price: | 13.11 CHF | |
● Pricing Date: | 04/04/2021 | |
● Type: | Medicine Authorised |
● Country: | Iceland | |
● Package Size: | 5 | |
● Public Price: | 11763 ISK | ( 7,587,135.00 LBP ) |
● Pack size unit used: | 5 | |
● Cost/Unit: | 2352,6 ISK | ( 1,517,040.00 LBP ) |
● Pharmacy Price: | 7484 ISK | ( 4827180 LBP ) |
● Reference: | Icelandic Medicines Agency | |
● Pricing Date: | 01/04/2020 | |
● Type: | Medicine Authorised |
● Country: | Cyprus | |
● Package Size: | 1 | |
● Public Price: | 13.73 EUR | ( 1,330,107.48 LBP ) |
● Pack size unit used: | 1 | |
● Cost/Unit: | 13,73 EUR | ( 1,259,388.00 LBP ) |
● Reference: | Cyprus Minister of Health | |
● Pricing Date: | 24/03/2021 | |
● Type: | Medicine Authorised |
● Country: | Qatar | |
● Package Size: | 1 | |
● Public Price: | 43 QAR | ( 1,055,994.00 LBP ) |
● Pack size unit used: | 1 | |
● Cost/Unit: | 43 QAR | ( 1,055,994.00 LBP ) |
● Pharmacy Price: | 35.19029072 QAR | ( 864203.15950176 LBP ) |
● Pricing Date: | 28/01/2021 | |
● Type: | Medicine Authorised |
● Country: | Norway | |
● Package Size: | 5 | |
● Public Price: | 646.5 NOK | ( 5,239,236.00 LBP ) |
● Pack size unit used: | 5 | |
● Cost/Unit: | 129,3 NOK | ( 1,045,416.00 LBP ) |
● Pharmacy Price: | 477.43 NOK | ( 3869092.72 LBP ) |
● Reference: | Norwegian Medicine Agency | |
● Pricing Date: | 05/11/2018 | |
● Type: | Medicine Withdrawn |
● Country: | Abu Dhabi | |
● Package Size: | 1 | |
● Public Price: | 42 AED | ( 1,014,762.00 LBP ) |
● Pack size unit used: | 1 | |
● Cost/Unit: | 42 AED | ( 1,014,762.00 LBP ) |
● Pharmacy Price: | 34.1 AED | ( 823890.1 LBP ) |
● Pricing Date: | 27/01/2021 | |
● Type: | Medicine Authorised |
● Country: | UAE | |
● Package Size: | 1 Vial (Dry) | |
● Public Price: | 42 AED | ( 1,014,762.00 LBP ) |
● Pack size unit used: | 1 | |
● Cost/Unit: | 42 AED | ( 1,014,762.00 LBP ) |
● Pharmacy Price: | 34.1 AED | ( 823890.1 LBP ) |
● Pricing Date: | 21/08/2019 | |
● Type: | Medicine Authorised |
● Country: | Bahrain | |
● Package Size: | 1x3ml | |
● Public Price: | 4.11 BHD | ( 977,086.74 LBP ) |
● Pack size unit used: | 1 | |
● Cost/Unit: | 4,11 BHD | ( 950,936.00 LBP ) |
● Reference: | nhra | |
● Pricing Date: | 04/07/2019 | |
● Type: | Medicine Authorised |
● Country: | Oman | |
● Package Size: | 1 | |
● Public Price: | 4.51 OMR | ( 1,040,610.34 LBP ) |
● Pack size unit used: | 1 | |
● Cost/Unit: | 4,51 OMR | ( 922,936.00 LBP ) |
● Pricing Date: | 19/02/2021 | |
● Type: | Medicine Authorised |
● Country: | UK | |
● Package Size: | 1 | |
● Public Price: | 8.79 GBP | ( 998,974.71 LBP ) |
● Pack size unit used: | 1 | |
● Cost/Unit: | 8,79 GBP | ( 909,192.00 LBP ) |
● Reference: | DMD | |
● Pricing Date: | 08/03/2021 | |
● Type: | Medicine Authorised |
● Country: | Kuweit | |
● Package Size: | 1+1 | |
● Public Price: | 3.51 KWD | ( 1,030,469.31 LBP ) |
● Pack size unit used: | 1 | |
● Cost/Unit: | 3,51 KWD | ( 880,743.00 LBP ) |
● Pharmacy Price: | 2.97 KWD | ( 871935.57 LBP ) |
● Pricing Date: | 07/02/2021 | |
● Type: | Medicine Authorised |
● Country: | KSA | |
● Package Size: | 1 | |
● Public Price: | 37.2 SAR | ( 879,408.00 LBP ) |
● Pack size unit used: | 1 | |
● Cost/Unit: | 37,2 SAR | ( 874,680.00 LBP ) |
● Reference: | sfda | |
● Pricing Date: | 16/01/2021 | |
● Type: | Medicine Authorised |
● Country: | Ireland | |
● Package Size: | 1 | |
● Public Price: | 9.02 EUR | ( 873,821.52 LBP ) |
● Pack size unit used: | 1 | |
● Cost/Unit: | 9,02 EUR | ( 871,884.00 LBP ) |
● Exfactory Price: | 9 EUR | |
● Pricing Date: | 09/10/2020 | |
● Type: | Medicine Authorised |
● Country: | France | |
● Package Size: | 1 | |
● Public Price: | 9.32 EUR | ( 902,884.32 LBP ) |
● Pack size unit used: | 1 | |
● Cost/Unit: | 9,32 EUR | ( 871,884.00 LBP ) |
● Reference: | ansm | |
● Pricing Date: | 15/05/2021 | |
● Type: | Medicine Non Marketed |
● Country: | Czech Republic | |
● Package Size: | 1 | |
● Public Price: | 194.01 CZK | ( 740,924.19 LBP ) |
● Pack size unit used: | 1 | |
● Cost/Unit: | 194,01 CZK | ( 740,886.00 LBP ) |
● Reference: | SUKL | |
● Pricing Date: | 28/02/2020 | |
● Type: | Medicine Authorised |
● Country: | Jordan | |
● Package Size: | 1 | |
● Public Price: | 4.01 JOD | ( 502,136.21 LBP ) |
● Pack size unit used: | 1 | |
● Cost/Unit: | 4,01 JOD | ( 500,884.00 LBP ) |
● Pharmacy Price: | 3.06 JOD | ( 383176.26 LBP ) |
● Reference: | JFDA | |
● Pricing Date: | 02/01/2021 | |
● Type: | Medicine Authorised |
● Country: | Egypt | |
● Package Size: | 1+1 | |
● Public Price: | 56.25 EGP | ( 102,656.25 LBP ) |
● Pack size unit used: | 1 | |
● Cost/Unit: | 56,25 EGP | ( 102,200.00 LBP ) |
● Pricing Date: | 02/12/2019 | |
● Type: | Medicine Authorised |
● Country: | The Netherlands |
● Package Size: | 1 |
● Reference: | Zorginstituut Nederland |
● Pricing Date: | 15/06/2019 |
● Type: | Medicine Non Marketed |
Note
You have to register to view this info
Drop File